Calculation
Total asset turnover | = | Net revenues1 | ÷ | Total assets1 | |
---|---|---|---|---|---|
Dec 31, 2023 | 0.40 | = | 54,318) | ÷ | 134,711) |
Dec 31, 2022 | 0.42 | = | 58,054) | ÷ | 138,805) |
Dec 31, 2021 | 0.38 | = | 56,197) | ÷ | 146,529) |
Dec 31, 2020 | 0.30 | = | 45,804) | ÷ | 150,565) |
Dec 31, 2019 | 0.37 | = | 33,266) | ÷ | 89,115) |
Dec 31, 2018 | 0.55 | = | 32,753) | ÷ | 59,352) |
Dec 31, 2017 | 0.40 | = | 28,216) | ÷ | 70,786) |
Dec 31, 2016 | 0.39 | = | 25,638) | ÷ | 66,099) |
Dec 31, 2015 | 0.43 | = | 22,859) | ÷ | 53,050) |
Dec 31, 2014 | 0.72 | = | 19,960) | ÷ | 27,547) |
Dec 31, 2013 | 0.64 | = | 18,790) | ÷ | 29,198) |
Dec 31, 2012 | 0.68 | = | 18,380) | ÷ | 27,008) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
1 US$ in millions
Comparison to Competitors
AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2023 | 0.40 | 0.28 | 0.47 | 0.28 | 0.53 | 0.43 | 0.51 | 0.56 | 0.36 | 0.26 | 0.40 | 0.43 |
Dec 31, 2022 | 0.42 | 0.38 | 0.48 | 0.37 | 0.58 | 0.43 | 0.51 | 0.54 | 0.71 | 0.51 | 0.42 | 0.46 |
Dec 31, 2021 | 0.38 | 0.40 | 0.42 | 0.35 | 0.58 | 0.40 | 0.52 | 0.46 | 0.72 | 0.45 | 0.63 | 0.41 |
Dec 31, 2020 | 0.30 | 0.39 | 0.36 | 0.29 | 0.53 | 0.36 | 0.47 | 0.52 | 0.03 | 0.27 | 0.50 | 0.47 |
Dec 31, 2019 | 0.37 | 0.37 | 0.20 | 0.29 | 0.57 | 0.36 | 0.52 | 0.55 | 0.00 | 0.31 | 0.53 | 0.44 |
Dec 31, 2018 | 0.55 | 0.34 | 0.64 | 0.42 | 0.56 | 0.34 | 0.53 | 0.51 | 0.00 | 0.34 | 0.57 | 0.43 |
Dec 31, 2017 | 0.40 | 0.27 | 0.62 | 0.39 | 0.51 | 0.37 | 0.49 | 0.46 | — | 0.31 | 0.67 | 0.37 |
Dec 31, 2016 | 0.39 | 0.28 | 0.58 | 0.37 | 0.55 | 0.53 | 0.51 | 0.42 | — | 0.31 | 0.70 | 0.40 |
Dec 31, 2015 | 0.43 | 0.29 | 0.52 | 0.43 | 0.56 | 0.62 | 0.53 | 0.39 | — | 0.29 | 0.73 | 0.41 |
Dec 31, 2014 | 0.72 | 0.28 | 0.47 | 0.54 | 0.53 | 0.71 | 0.57 | 0.43 | — | 0.29 | 0.73 | 0.39 |
Dec 31, 2013 | 0.64 | 0.28 | 0.42 | 0.55 | 0.66 | 0.48 | 0.54 | 0.42 | — | 0.30 | 0.71 | 0.41 |
Dec 31, 2012 | 0.68 | 0.31 | 0.49 | 0.55 | 0.66 | 0.44 | 0.55 | 0.45 | — | 0.32 | 0.66 | 0.46 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
AbbVie Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
AbbVie Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Dec 31, 2023 | 0.40 | 0.40 |
Dec 31, 2022 | 0.42 | 0.48 |
Dec 31, 2021 | 0.38 | 0.45 |
Dec 31, 2020 | 0.30 | 0.38 |
Dec 31, 2019 | 0.37 | 0.39 |
Dec 31, 2018 | 0.55 | 0.45 |
Dec 31, 2017 | 0.40 | 0.40 |
Dec 31, 2016 | 0.39 | 0.41 |
Dec 31, 2015 | 0.43 | 0.42 |
Dec 31, 2014 | 0.72 | 0.45 |
Dec 31, 2013 | 0.64 | 0.43 |
Dec 31, 2012 | 0.68 | 0.45 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Comparison to Industry (Health Care)
AbbVie Inc. | Health Care | |
---|---|---|
Dec 31, 2023 | 0.40 | 0.80 |
Dec 31, 2022 | 0.42 | 0.81 |
Dec 31, 2021 | 0.38 | 0.76 |
Dec 31, 2020 | 0.30 | 0.70 |
Dec 31, 2019 | 0.37 | 0.71 |
Dec 31, 2018 | 0.55 | 0.67 |
Dec 31, 2017 | 0.40 | 0.68 |
Dec 31, 2016 | 0.39 | 0.70 |
Dec 31, 2015 | 0.43 | 0.67 |
Dec 31, 2014 | 0.72 | 0.72 |
Dec 31, 2013 | 0.64 | 0.69 |
Dec 31, 2012 | 0.68 | 0.69 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).